Sidebar Ads

Sunday, August 18, 2019

Novartis executive sold shares before drug data manipulation made public

An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration (FDA) announced data from tests of its gene therapy Zolgensma had been manipulated.


from Reuters: Business News https://ift.tt/2P0gjQd

Related Posts:

0 comments:

Post a Comment

Apple encrypted data row hearing begins in secret

The BBC - along with civil liberties groups and some US politicians - argue the case should be heard in public. from BBC News https://ift....